189 related articles for article (PubMed ID: 17158821)
1. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour.
Sparago A; Russo S; Cerrato F; Ferraiuolo S; Castorina P; Selicorni A; Schwienbacher C; Negrini M; Ferrero GB; Silengo MC; Anichini C; Larizza L; Riccio A
Hum Mol Genet; 2007 Feb; 16(3):254-64. PubMed ID: 17158821
[TBL] [Abstract][Full Text] [Related]
2. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour.
Cerrato F; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Rinaldi MM; Boccuto L; Neri G; Magnani C; D'Angelo P; Collini P; Perotti D; Sebastio G; Maher ER; Riccio A
Hum Mol Genet; 2008 May; 17(10):1427-35. PubMed ID: 18245780
[TBL] [Abstract][Full Text] [Related]
3. Inherited and Sporadic Epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor.
Riccio A; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Ferrero GB; Silengo MC; Russo S; Larizza L; Cerrato F
Endocr Dev; 2009; 14():1-9. PubMed ID: 19293570
[TBL] [Abstract][Full Text] [Related]
4. The molecular function and clinical phenotype of partial deletions of the IGF2/H19 imprinting control region depends on the spatial arrangement of the remaining CTCF-binding sites.
Beygo J; Citro V; Sparago A; De Crescenzo A; Cerrato F; Heitmann M; Rademacher K; Guala A; Enklaar T; Anichini C; Cirillo Silengo M; Graf N; Prawitt D; Cubellis MV; Horsthemke B; Buiting K; Riccio A
Hum Mol Genet; 2013 Feb; 22(3):544-57. PubMed ID: 23118352
[TBL] [Abstract][Full Text] [Related]
5. A novel microdeletion in the IGF2/H19 imprinting centre region defines a recurrent mutation mechanism in familial Beckwith-Wiedemann syndrome.
De Crescenzo A; Coppola F; Falco P; Bernardo I; Ausanio G; Cerrato F; Falco L; Riccio A
Eur J Med Genet; 2011; 54(4):e451-4. PubMed ID: 21571108
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome.
Gaston V; Le Bouc Y; Soupre V; Burglen L; Donadieu J; Oro H; Audry G; Vazquez MP; Gicquel C
Eur J Hum Genet; 2001 Jun; 9(6):409-18. PubMed ID: 11436121
[TBL] [Abstract][Full Text] [Related]
7. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor.
Prawitt D; Enklaar T; Gärtner-Rupprecht B; Spangenberg C; Oswald M; Lausch E; Schmidtke P; Reutzel D; Fees S; Lucito R; Korzon M; Brozek I; Limon J; Housman DE; Pelletier J; Zabel B
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4085-90. PubMed ID: 15743916
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders.
Demars J; Shmela ME; Rossignol S; Okabe J; Netchine I; Azzi S; Cabrol S; Le Caignec C; David A; Le Bouc Y; El-Osta A; Gicquel C
Hum Mol Genet; 2010 Mar; 19(5):803-14. PubMed ID: 20007505
[TBL] [Abstract][Full Text] [Related]
9. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome.
Sparago A; Cerrato F; Vernucci M; Ferrero GB; Silengo MC; Riccio A
Nat Genet; 2004 Sep; 36(9):958-60. PubMed ID: 15314640
[TBL] [Abstract][Full Text] [Related]
10. Beckwith-Wiedemann syndrome caused by maternally inherited mutation of an OCT-binding motif in the IGF2/H19-imprinting control region, ICR1.
Poole RL; Leith DJ; Docherty LE; Shmela ME; Gicquel C; Splitt M; Temple IK; Mackay DJ
Eur J Hum Genet; 2012 Feb; 20(2):240-3. PubMed ID: 21863054
[TBL] [Abstract][Full Text] [Related]
11. The number of the CTCF binding sites of the H19/IGF2:IG-DMR correlates with DNA methylation and expression imprinting in a humanized mouse model.
Freschi A; Del Prete R; Pignata L; Cecere F; Manfrevola F; Mattia M; Cobellis G; Sparago A; Bartolomei MS; Riccio A; Cerrato F
Hum Mol Genet; 2021 Jul; 30(16):1509-1520. PubMed ID: 34132339
[TBL] [Abstract][Full Text] [Related]
12. A novel IGF2/H19 domain triplication in the 11p15.5 imprinting region causing either Beckwith-Wiedemann or Silver-Russell syndrome in a single family.
Jurkiewicz D; Kugaudo M; Skórka A; Śmigiel R; Smyk M; Ciara E; Chrzanowska K; Krajewska-Walasek M
Am J Med Genet A; 2017 Jan; 173(1):72-78. PubMed ID: 27612309
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome.
Catchpoole D; Lam WW; Valler D; Temple IK; Joyce JA; Reik W; Schofield PN; Maher ER
J Med Genet; 1997 May; 34(5):353-9. PubMed ID: 9152830
[TBL] [Abstract][Full Text] [Related]
14. Role of genomic imprinting in Wilms' tumour and overgrowth disorders.
Reeve AE
Med Pediatr Oncol; 1996 Nov; 27(5):470-5. PubMed ID: 8827076
[TBL] [Abstract][Full Text] [Related]
15. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome.
Cooper WN; Luharia A; Evans GA; Raza H; Haire AC; Grundy R; Bowdin SC; Riccio A; Sebastio G; Bliek J; Schofield PN; Reik W; Macdonald F; Maher ER
Eur J Hum Genet; 2005 Sep; 13(9):1025-32. PubMed ID: 15999116
[TBL] [Abstract][Full Text] [Related]
16. Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer.
Murrell A; Ito Y; Verde G; Huddleston J; Woodfine K; Silengo MC; Spreafico F; Perotti D; De Crescenzo A; Sparago A; Cerrato F; Riccio A
PLoS One; 2008 Mar; 3(3):e1849. PubMed ID: 18365005
[TBL] [Abstract][Full Text] [Related]
17. A novel large deletion of the ICR1 region including H19 and putative enhancer elements.
Fryssira H; Amenta S; Kanber D; Sofocleous C; Lykopoulou E; Kanaka-Gantenbein C; Cerrato F; Lüdecke HJ; Bens S; Riccio A; Buiting K
BMC Med Genet; 2015 May; 16():30. PubMed ID: 25943194
[TBL] [Abstract][Full Text] [Related]
18. Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway.
Brown KW; Villar AJ; Bickmore W; Clayton-Smith J; Catchpoole D; Maher ER; Reik W
Hum Mol Genet; 1996 Dec; 5(12):2027-32. PubMed ID: 8968759
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific insulator function at H19/Igf2 revealed by deletions at the imprinting control region.
Ideraabdullah FY; Thorvaldsen JL; Myers JA; Bartolomei MS
Hum Mol Genet; 2014 Dec; 23(23):6246-59. PubMed ID: 24990148
[TBL] [Abstract][Full Text] [Related]
20. Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1.
Weksberg R; Nishikawa J; Caluseriu O; Fei YL; Shuman C; Wei C; Steele L; Cameron J; Smith A; Ambus I; Li M; Ray PN; Sadowski P; Squire J
Hum Mol Genet; 2001 Dec; 10(26):2989-3000. PubMed ID: 11751681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
